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Abstract 
Surgeons provide patients with information before surgery although standards of information 
provision are lacking and practice varies.  The development and use of a ‘core information set’ may 
improve understanding and decision-making. A core set is a minimum set of information to use in all 
consultations as a baseline before surgery. This study developed a core information set to use during 
information provision prior to surgery for oesophageal cancer. 
All potential information was identified from the literature, observations of clinical consultations and 
interviews with patients. The information was synthesised and used to create a questionnaire 
survey. Stakeholders’ (patients and professionals) were surveyed twice to assess views of 
information importance from “not essential” to “absolutely essential” using Delphi methods. Items 
not meeting pre-defined criteria were discarded after each survey round. Items retained after the 
second round were voted on in stakeholders meetings to agree the final core set.   
Initially 67 information items were identified from the multiple sources. Survey response rates were 
good, 76.5% (185/242) and 54.8% (126/230) for patients and professionals respectively (first round) 
and > 83% in the both groups thereafter. Health professionals rated short term clinical outcomes 
most highly whereas patients rated longer endpoints as important.  In the consensus meetings nine 
items were identified in the core set to encompass issues of importance to both stakeholder groups. 
This study has established a core information set to use for surgery for oesophageal cancer. Further 
work will evaluate its use in practice.  
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Introduction 
The main stay of curative treatment for oesophageal cancer is surgery which may be combined with 
neoadjuvant chemotherapy or chemoradiotherapy. Although many advances in surgery for 
oesophageal cancer have occurred over the past decade, the long term outcomes are generally poor 
and peri-operative risks remain high1. The risk of in-hospital death after oesophagectomy is between 
2 and 4%, serious complications occur in about 20% of patients. Surgery also has an immediate 
major detrimental impact on health-related quality of life (HRQL). Survival after surgery is in the 
region of 30 to 50% at five years and HRQL deficits persist in long term survivors2-4. The decision to 
undergo this surgery, therefore, is difficult. It is informed by discussion between surgeons and 
patients about the short term risks and long term outcomes and it includes consideration of tumour 
stage, patient co-morbidities, and, surgeon and patient preferences. Current United Kingdom and 
international policy supports the use of shared decision-making between surgeons and patients with 
exchange of information5-6. Whilst there is an emphasis for surgeons to provide high quality 
information to inform the decisions, the actual information provided in consultations is largely 
unknown and standards for information provision and methos for informed consent for surgery are 
limited7. Indeed, the driver behind many consultations focuses on the medico-legal requirements for 
surgeons to discuss inherent risks of surgery rather than focus upon patient information needs8-10. 
  
Recent surveys in oesophago-gastric cancer and other cancer sites have examined patients’ 
preferences for information8,10. Generally patients prefer more rather than less information and 
studies show that patients want surgeons to raise sensitive issues (such as prognosis) in clinic 
appointments rather than having to request this information themselves8-11. There is therefore 
recognition that information provision is important, however, the amount of information that could 
be communicated before surgery is large and it is unclear what information is critical to inform 
understanding. It is also important to avoid overwhelming patients with data which may reduce 
understanding12. One method for focussed provision of information before surgery is to identify a 
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‘core information (disclosure) set’ for specific procedures13.  Core information represents the 
minimum information to be disclosed by a clinician in all consultations for a particular operation. The 
idea of the “core information set” was described in the bioethical literature over 30 years ago where 
‘core disclosure’ was recommended. It was suggested that a ‘core disclosure set’ would include 
information of importance to key stakeholders (i.e. patients and surgeons) and be feasible to 
communicate in a regular clinical consultation. Although a seminal idea, this has hitherto not been 
further explored14.  This study presents the development of a core information (disclosure) set for 
surgeons to use in consultations with patients before surgery for oesophageal cancer and considers 
how this can be used in future practice to improve shared decision-making and informed consent. 
 
Methods 
Development of the core set involved three phases. Phase 1 generated an exhaustive list of all the 
information that could be communicated before surgery for oesophageal cancer. This long list was 
reduced by grouping similar pieces of information together and these were used to create 
questionnaire items. In phase 2 the questionnaire was used to survey stakeholders’ views of the 
importance of each item using Delphi methods. Phase 3 finalised the core information set to be 
feasible to use in practice through separate consensus meetings with surgeons and patients (Table 
1).  
 
Phase 1 – generation of a questionnaire 
Several sources were used to identify all possible pieces of information; i) systematic searches of the 
international clinical and patient reported outcome literature, ii) analyses of written patient 
information leaflets used for oesophageal cancer surgery in UK hospitals, iii) analyses of audio-
recorded consultations between patients and surgeons in which consent for surgery was discussed, 
and, iv) analyses of interviews with patients prior to surgery15-19. Duplicates were removed and a 
long list of information was created. The clinical items were categorised independently by two 
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members of the study team into domains (e.g. 30-day and 90-day mortality were within the 
‘mortality’ domain). Patient reported outcomes were grouped into domains (e.g. ability to walk and 
activity levels were within the physical function domain) and verified by two researchers and a 
patient representative15. Items from patient information leaflets were independently categorised by 
a surgical registrar and a cancer nurse specialist. Discrepancies were resolved by discussion with the 
study lead. Overlapping domains between data sources were condensed producing a final list of 
domains.  
 
The final domains were operationalised into questionnaire items using lay language with the medical 
terminology included in parentheses. The purpose of the questionnaire was to allow stakeholder 
groups to rate items from 1 to 9, where 1 was ‘not essential’ and 9, ‘absolutely essential’ 
information. The questionnaire was piloted by four members of a patient support group for face 
validity, understanding and acceptability. Following this modifications were made.  The 
questionnaire was translated into Dutch by a professional translator and checked by members of the 
study team.  
 
Phase 2 - Delphi consensus methods 
Delphi consensus methods were used to inform consensus on the core information set20. The 
questionnaire developed in Phase 1 was sent to key stakeholders including oesophageal cancer 
surgeons, clinical nurse specialists and patients who were awaiting or who had undergone surgery 
for oesophageal cancer (Round 1). Surgeons and nurses were identified via an oesophageal cancer 
meeting, the UK Association of Upper Gastro-Intestinal Surgeons and by personal knowledge of 
surgeons in oesophageal cancer surgery centres. Patients were recruited from Bristol and 
Birmingham in the UK, and from the Academic Medical Centre in The Netherlands. In the UK, 
participants were approached by post and responders consenting to participate were sent the 
questionnaire with a stamp addressed envelope. One reminder was posted to patients if necessary. 
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Health professionals were approached in a similar way with an email reminder if required.  In The 
Netherlands, participants were contacted by telephone and those agreeing to participate received 
postal questionnaires. Health professionals were contacted by email and then posted 
questionnaires. First round questionnaires were analysed and participants sent a second 
questionnaire (Round 2) which contained a reduced number of items. In Round 2, participants were 
asked to re-prioritise each item. Round 2 questionnaires also contained feedback from Round 1. All 
questionnaires contained the individual’s score 1 and group feedback (summarized as a mean score 
in order to be readily understood by participants). Some participants had feedback for both 
stakeholder groups and others had feedback for their own stakeholder group (details of this 
exploratory substudy will be described separately). Participants were asked to rescore each item 
between 1 and 9; questionnaires were then analysed to determine which items should be retained 
and presented in the consensus meetings. The Round 2 survey was carried out using retained items.  
 
Phase 3 – Face to face consensus meetings 
Two consensus meetings were held in Bristol; the first with health professionals and the second with 
patients and carers. Because oesophagectomy represents major surgery and post-operative recovery 
is often lengthy, carers were also invited to participate in the patients’ meeting in recognition of 
their crucial role in decision making. The meetings were held in January and March 2013 
respectively. Attendees were all from the UK and had completed the questionnaire surveys and 
responded to an invitation to attend a consensus meeting. The retained items from the second 
survey were presented in the meetings and participants asked to anonymously rate their 
importance. Anonymised voting took place to ask participants to select ‘In’, ‘Out’ or ‘Unsure’ for 
each time. Histograms and descriptive statistics were created for each item during the meeting 
displayed to the participants. Where there were apparent bimodal distributions (similar number of 
participants voted ‘In’ or ‘Out’) these were explored by discussion to see if there was polarized 
opinion within the stakeholder groups.  
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Sample size  
There are no agreed methods to set the sample size for Delphi surveys or consensus meetings. 
Therefore an opportunistic approach was used with the aim of obtaining at least 100 respondents 
for each group for the survey and a group in which discussion could take place (<30) for the 
consensus meetings.   
 
Data analysis 
In Round 1 of the survey, items were categorized as “essential” and retained for Round 2 if they 
were rated between 7 and 9 by over 50% of respondents and between 1 and 3 by less than 15%.  
Items not meeting these criteria were discarded. Mean scores were calculated for each retained 
item. The process of discarding items was performed separately for patient and health professional 
groups.  Round 2 responses were analysed with a stricter cut-off criteria, retaining items rated 
between 7 and 9 by over 70% of respondents, and between 1 and 3 by less than 15%.  There are no 
agreed methods for selecting cut off criteria within Delphi studies therefore the criteria were 
selected after discussion within the writing group and collaborators. The items retained after Round 
2 were considered in phase 3 consensus meetings. In the meeting each item was discussed and 
voting took place which asked attendees to vote items as ‘in’, ‘out’, or, ‘unsure’. Voting was 
undertaken using electronic keypads to ensure anonymity. The unsure items were re-discussed with 
further voting and discussion. All items retained from both meetings were included in the final core 
set. 
 
Results 
Phase 1 
Review of all data sources describing information relating to oesophageal cancer surgery generated 
901 individual pieces of information, which were categorised into 67 items within the Round 1 
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questionnaire. These covered items about immediate and in-hospital surgical complications, longer 
term side effects, peri-operative processes and experiences, longer term quality of life and cancer 
survival and related events (e.g. local and distant recurrence). 
Phase 2 
In Round 1 of the Delphi survey, response rates were 185/242 (76.5%) for patients and 126/230 
(54.8%) for health professionals. The majority of patients and health professionals were male (75.1% 
and 72.2% respectively) (Table 2). In the health professional group 84 (67.7%) were consultant 
surgeons, 29(23.0%) nurse specialists and 13 (10.4%) were trainees and most, 98 (77.8%), were from 
the UK. Similar demographics were observed amongst patients from the UK and The Netherlands.  
In Round 1 health professionals rated information about short term clinical risks (anastomotic 
leakage, in-hospital mortality and inoperability) most highly where as long term outcomes (e.g. 
information about survival, disease recurrence) were rated highest in the patient group (Table 3). By 
the time of the Round 2 survey, 11 patients had died and 145 of 174 patient questionnaires were 
returned (response rate 83.3%). The response rate for health professionals in Round 2 was 84.9% 
(107/126). Demographics of patient and professional participants were similar in Rounds 1 and 2. 
Provision of group feedback and application of the more stringent cut-off criteria in Round 2 resulted 
in 20 items being retained for the patient group and 22 items for the professional group. There were 
15 overlapping items between groups. 
Phase 3 consensus meetings 
The two consensus meetings were attended by 18 professionals and 16 patients / 7 carers 
respectively. In the initial anonymised voting at the professionals’ meeting five items were voted ‘in’, 
eight ‘out’, and, nine ‘unsure’.  In the patients’ meeting it was, five ‘in’, three, ‘out’ and 12 ‘unsure’ 
(Table 4). Extensive discussion ensued in both meetings and it was recognised that items sometimes 
overlapped in content and meaning. Where appropriate, therefore, items were merged to form a 
single item. For example, it was agreed that items about ‘cancer recurrence’ and ‘survival’ should be 
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combined as a single item ‘overall survival’. Similarly, items about morbidity (re-operation, 
anastomotic leak and respiratory morbidity) were combined as, ‘in-hospital complications’. In both 
meetings where items were initially voted ‘unsure’ further discussion and further voting took place 
(Table 4). There were two items where the stakeholder groups had opposing views; experiences on 
admission and information about hospital stay. The groups agreed that these were overlapping and 
they were therefore combined and kept ‘in’ in the final core set. After both stakeholder meetings 
the two core sets were combined and the final core information set had eight items (Table 5). The 
logical sequence for discussing items with patients is also shown in Table 5.   
 
Discussion 
This study has developed a core information set for surgeons to disclose in consultations with 
patients undergoing oesophageal cancer surgery. The core set includes items of importance to 
health professionals and patients. It was developed following detailed scrutiny of the literature and 
written hospital information leaflets as well as in-depth analysis of current practice and interviews 
with patients. The final items were selected by an iterative consensus process including views of 
over 250 health professionals and patients. The core set contains information about processes 
before surgery and during hospital admission, short term risks and clinical outcomes. It includes 
items about long term quality of life and survival. It is now recommended that surgeons (and 
specialist nurses) use the core information set during consultations with patients before surgery. 
This may catalyse discussion relevant to patients’ information needs and/or the needs of surgeons to 
expand details related to surgical morbidity. It is recommended that further work to examine how it 
is optimally communicated in practice is undertaken. 
 
The concept of provision of ‘core information’ for surgery is not new but this is the first attempt that 
we are aware of to develop a core set and establish methods to do this. Other approaches for 
uniform information provision and for improving consultations and consent are available. Patient 
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decision aids are designed to help people make decisions in situations where there are alternative 
treatments available and there is data from high quality randomised trials describing the different 
treatments20. The purpose and use of decision aids therefore differs to that of a core information set 
because of the focus of considering treatment alternatives. There are also aids available for 
communicating information about risks and for supporting patients prior to consultations before 
surgery21-23. These would be useful in the delivery of a core information set, but the development of 
a core set of information to be used as baseline information provision for a specified operation is 
unique. Whilst core information sets are recommended to use as minimum information provision it 
is important to note that the core information can be supplemented with additional information of 
importance to patients or surgeons. 
 
Although this work is novel and has been carefully conducted with participation from national and 
international key stakeholder groups there are some methodological limitations.  Consensus was 
obtained by surveys and meetings which may not have appealed to a full range of stakeholders and 
it is possible that non-participants may value information differently to participants (the response 
rates for health professionals in the first survey round was 54%), additionally there was a limited 
number of international health professionals surveyed which may influence generalisability.  There is 
also a concern that this work focussed on pre-operative information provision although patients 
surveyed had often undergone surgery. The views of patients after surgery may differ from the pre-
operative setting. This issue has partly been addressed by work undertaken collaboratively with the 
Amsterdam group24.  In this survey patients and health professionals were specifically asked to 
prioritise information to be received after surgery. This studied showed that patients wanted 
information about whether the cancer had been removed (and cured), data about eating and 
drinking and subsequent recovery and possible complications. Both the current work and this work 
from the Netherlands, therefore highlight the importance of provision of information about long 
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term survival and quality of life – things of key importance to patients that can be difficult to discuss 
in consultations because of the sometimes poor long term outcome of surgery.  
 
This work represents the first step in the area of work and now it is necessary to develop methods to 
best communicate the information in practice. Surgeons are familiar with communicating technical 
data about surgery and short term risks, they are also trained to talk about a diagnosis of cancer. 
Imparting sensitive information about prognosis, however, is more difficult and doing this well 
require training and may be supported by using adjuncts to information provision including graphical 
presentation of survival data, or information about quality of life outcomes21, 22, 25, 26. It is also 
possible that the core information set could be communicated by different personnel (surgeons and 
nurses), this could be agreed by local teams and that hospital written information leaflets be 
designed to contain the core information set. This will ensure uniform information provision from all 
sources to help patients’ gain sufficient understanding to undergo surgery for oesophageal cancer.  
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Table 1.  Summary of methods to develop a core disclosure set 
Phase 1 Identification of all information relevant to the decision to undergo surgery 
 Literature searches to identify clinical outcomes and patient reported outcomes 
 Observations of clinic consultations and interviews with patients and surgeons to 
identify information used in practice and considered important 
 Review of UK written hospital information leaflets for the type of surgery 
This produces a list of all potential information  
 The list is grouped into information domains*   
 The domains inform questionnaire items to use in phase 2 
Phase 2 Prioritisation of information by key stakeholders  
 Stakeholders are surveyed and asked to prioritise each piece of information  
 Results of the survey are fed back to stakeholders in a second survey (Delphi 
methods) and they are asked to re-prioritise each piece of information 
 Data are analysed by the research group using pre-defined criteria to reduce the list 
of information  
Two information lists, (from patients and health professionals) are ready for phase 3 
Phase 3 Stakeholder consensus meetings   
 The items are presented to each group and anonymised voting rated items as, ‘in’, 
‘out’ or ‘unsure’ 
 Items rated as ‘unsure’ are discussed and more voting is undertaken  
The process produces two sets (one selected by patients, one by professionals). These 
are compared and condensed into one core information set) 
 
*A domain can be defined as a broad category of information. For example, haemorrhage, 
the need for blood transfusion and intra-operative blood loss were all categorised into a 
single domain termed ‘blood loss’. 
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Table 2. Clinical and socio-demographic details of patient participant in the Delphi survey 
 
 Round 1 
n=185 
Round 2 
n=145 
Mean age in years (range) 66.5 (38.3 to 82.7) 
 
66.6 (38.3 to 80.3) 
Gender (% men) 139 (75.1) 
 
109 (75.2) 
Institution (%) 
  Bristol, UK 
  AMC, The Netherlands 
 
89 (48.1) 
96 (51.9) 
 
 
69 (47.6) 
76 (52.4) 
Length of in-patient stay (%) 
   < 14 days 
   2-4 weeks 
   >4 weeks 
   Unknown 
 
110 (59.5) 
53 (28.7) 
12 (6.5) 
10 (5.4) 
 
 
87 (60.0) 
44 (30.4) 
8 (5.5) 
6 (4.1) 
Experienced complications 
requiring a re-operation (%) 
29 (15.7) 24 (16.6) 
Pre-operative treatment (%) 
  Chemotherapy 
  Radiotherapy 
 
141 (76.2) 
84 (45.4) 
 
 
110 (75.9) 
68 (46.9) 
Highest level of education (%) 
   School GCSE/A level 
   Vocational qualification 
   University or higher degree 
   Other 
   Unknown 
 
65 (35.1) 
50 (27.0) 
34 (18.8) 
25 (13.5) 
11 (6.0) 
 
 
50 (34.5) 
41 (28.3) 
29 (20.0) 
17 (11.7) 
8 (5.5) 
Marital status (%) 
   Single 
   Divorce/separated 
   Married/co-habiting 
   Widowed 
   Unknown   
 
9 (4.9) 
14 (7.5) 
147 (79.5) 
13 (7.0) 
2 (1.1) 
 
 
8 (5.5) 
10 (7.5) 
115 (79.3) 
11 (7.6) 
1 (0.7) 
 
 
UK – United Kingdom, AMC – Amsterdam Medical Centre (note no differences were seen 
between UK and Dutch patients’ views in round 1 or round 2) 
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Table 3.  Round 1 mean scores for top 10 items, ranked by stakeholder group 
 
Information Item Professionals’ mean 
rating (SD), n=126 
Information Item Patients’ mean 
rating (SD), n=185 
Anastomotic leak 8.65 (0.93) Cancer recurrence 7.88 (1.64) 
In-hospital death 8.37 (1.39) Survival 7.80 (1.88) 
Type of surgery 8.17 (1.18) Inoperability  7.74 (1.81) 
Long term general health 8.06 (1.47) Information about risks 
related to co-morbidity 
7.66 (1.67) 
Inoperability 8.03 (1.81) Long term quality of life 7.68 (1.40) 
Information about 
hospital experience 
7.98 (1.49) Recovery milestones 
after discharge  
7.51 (1.74) 
Respiratory 
complications 
7.88 (1.52) Long term general 
health 
7.47 (1.43) 
Re-operation 7.86 (1.38) Anastomotic stricture 7.47 (1.84) 
In-hospital recovery 7.83 (1.58) In-hospital recovery 7.46 (1.59) 
Long term quality of life 7.80 (1.63) Information about 
hospital experience 
7.44 (1.80) 
 
SD = standard deviation
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Table 4  Decisions made at the two consensus meetings (Phase 3) 
 
 Item   ‘In’ Uncertain Item ‘Out’ Initial views Final decision 
 Pt HCP Pt HCP Pt HCP Pt HCP  
Survival 16 15 3 0 0 3 In In Retain ‘Overall 
survival ‘* 
Inoperability 13 14 1 2 5 2 Unsure In Retain item 
Cancer recurrence 15 12 1 3 3 3 Unsure In Retain ‘Overall 
survival ‘* 
Anastomotic leak 12 11 2 2 5 5 Unsure Unsure Retain ‘in-hospital 
complications’**  
Long term quality of life 16 11 1 0 2 7 In Unsure Retain item 
In-hospital recovery 16 10 0 2 3 6 In  Unsure Retain ‘recovery 
milestones’** 
Recovery after discharge 11 10 0 0 8 8 Unsure Unsure Retain ‘recovery 
after discharge’ *
 
Preparation for surgery 18 9 0 2 1 7 Unsure Unsure Retain ‘recovery 
milestones’** 
Experience on admission  17 6 0 1 2 11 In  Out Retain ‘recovery 
milestones’** 
Hospital stay & experience  16 7 0 0 3 11 In  Out Retain ‘recovery 
milestones’** 
Type of surgery 11 7 2 2 6 9 Unsure Unsure Retain item 
In-hospital pain control 12 7 0 1 7 10 Unsure Unsure Retain ‘recovery 
milestones’** 
Physical function 11 6 2 2 6 10 Unsure Out Voted out 
Reflux symptoms 13 6 0 2 6 10 Unsure Out Voted out 
Long term general health 9 4 1 3 9 11 Out  Out Voted out 
Respiratory complications  n/a 10 n/a 5 n/a 3 n/a  Unsure Retain ‘in-hospital 
complications’**  
Re-operation n/a 10 n/a 0 n/a 8 n/a  Unsure Retain ‘in-hospital 
complications’** 
In-hospital death n/a 18 n/a 0 n/a 0 n/a In Retain item 
Role function n/a 5 n/a 4 n/a 9 n/a  Out Voted out 
Pain/discomfort n/a 3 n/a 3 n/a 12 n/a Out Voted out 
Body image/weight loss n/a 3 n/a 1 n/a 14 n/a  Out Voted out 
Eating and drinking n/a 15 n/a 0 n/a 3 n/a In Retain ‘eating & 
drinking’* 
Dumping symptoms 12 n/a 0 n/a 7 n/a Unsure  n/a  Voted out 
Fatigue 10 n/a 0 n/a 9 n/a Out  n/a Voted out 
Dysphagia 12 n/a 1 n/a 6 n/a Unsure  n/a  Retain ‘eating & 
drinking’* 
Sleeping problems 8 n/a 0 n/a 10 n/a Out  n/a Voted out 
Follow up arrangements 11 n/a 0 n/a 8 n/a Unsure  n/a Retain ‘recovery 
after discharge’ * 
n/a=not applicable since not retained following the Delphi survey, * item retained & merged with 
another item, ** item retained & merged with two items 
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Table 5  The eight items in the final core information set 
 
 
Experience on admission & in-hospital  
 
Expected in-hospital experiences and milestones to recovery (incl. length of stay & pain control) 
Chances of inoperability 
Information about major complications (re-operation, leak, respiratory problems) 
In-hospital mortality 
 
Experience after discharge (incl. length of stay & pain control) 
 
Expected recovery milestones after discharge & follow up   
Impact on eating & drinking in the longer term 
Long term overall quality of life data 
Long term survival 
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